Search clinical trials for: Alpha-1 MP

Total 19899 results

Kamada, Ltd.
Syneos Health

Recruiting

Evaluate Efficacy and Safety of "Kamada-AAT for Inhalation" in Patients With AATD (InnovAATe)

Alpha 1-Antitrypsin Deficiency

United Kingdom, Sweden, Ireland, Netherlands, Belgium, Finland
Medical University of Vienna

Unknown

Objective Assessment of Macular Function at Retinal and Cortical Levels

Retina Disorder | Macula; Degeneration, Congenital or Hereditary
Syrian Private University

Completed

Silodosin in Management of Lower Ureteral Stones

Stone, Kidney

Syrian Arab Republic
Centre Hospitalier Departemental Vendee

Terminated

Effectiveness of Silodosin in Medical Expulsive Therapy for Ureteral Pelvic Stone From 4 to 10 mm. (SiloMET)

Kidney Stone | Expulsive Medical Therapy

France
Sanofi

Completed

SAMBA: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin

Prostatic Hyperplasia

Colombia, Mexico, Ecuador, Guatemala
Blessing Corporate Services, Inc
Takeda Pharmaceuticals North America, Inc.

Withdrawn

Aralast NP With Antiviral Treatment and Standard of Care Versus Antiviral Treatment With Standard of Care in Hospitalized Patients With Pneumonia and COVID-19 Infection

Pneumonia, Viral | Covid19

United States
Medical University of Warsaw

Completed

Glucomannan for the Treatment of Abdominal Pain-related Functional Gastrointestinal Disorders in Childhood

Functional Gastrointestinal Disorders

Poland
Sun Yat-sen University
SciClone Pharmaceuticals

Completed

The Efficacy and Safety of Ta1 for Sepsis (TESTS)

Sepsis

China
Unity Health Toronto
University of Toronto; Dicofarm

Completed

Konjac-Mannan Improves Glycemia and Other Risk Factors for CHD in T2DM

Coronary Heart Disease | Type2 Diabetes
M.D. Anderson Cancer Center

Terminated

Doxercalciferol in Recurrent Pediatric Solid Tumors

Solid Tumors

United States
Sun Yat-sen University

Completed

Efficacy of Thymosin alpha1 for Severe Sepsis (ETASS)

Severe Sepsis

China
MicroPort Orthopedics Inc.

Recruiting

EVOLUTION® Revision STEMMED CS Post Market Clinical Follow-up Study Protocol

Joint Diseases

Italy
Mayo Clinic
National Cancer Institute (NCI)

Withdrawn

Autophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR Trial

Hematopoietic and Lymphoid Cell Neoplasm | Sarcoma | Lymphoma | Breast Carcinoma

United States
Centre Hospitalier Universitaire de Nīmes

Recruiting

Efficacy of Alpha-blockers (Tamsulosin) in the Treatment of Symptomatic Dysuria in Multiple Sclerosis in Women (ALPHA-SEP)

Multiple Sclerosis | Lower Urinary Tract Symptoms | Urinary Retention | Voiding Dysfunction | Dysuria

France
National Institute of Diabetes and Digestive and...
University of California, San Diego; The Cleveland Clinic; Duke University; University... and other collaborators

Recruiting

Vitamin E Dosing Study (VEDS)

Nonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis

United States
Sheba Medical Center

Recruiting

Tamsulosin for Thyroid Lid Retraction

Thyroid Eye Disease | Eyelid Diseases

Israel
Wake Forest University Health Sciences

Terminated

The Effect of Tamsulosin on Postoperative Urinary Retention

Urinary Retention

United States
Mansoura University

Active, not recruiting

The Efficacy and Safety of Medical Expulsive Therapy After Extracorporeal Shock Wave Lithotripsy (ESWL) in Pediatric Urolithiasis

Stone, Kidney | Pediatric Disorder | Stone, Urinary | Extracorporeal Shock Wave Lithotripsy | Tamsulosin

Egypt
University of Manitoba

Suspended

Prazosin Use in Adults With Anxiety Disorders

Anxiety Disorders | Anxiety

Canada
Milton S. Hershey Medical Center

Completed

Effectiveness of Prazosin in Bulimic Patients Experiencing Nightmares Due to PTSD

Stress Disorders, Post-Traumatic | Bulimia Nervosa

United States
Augusta University

Completed

Reducing Suicidal Ideation Through Treatment of Nightmares-Post Traumatic Stress Disorder (PTSD) (REST-ON PTSD)

Suicidal Ideation | Post Traumatic Stress Disorder | Nightmares

United States
Rennes University Hospital
Ministry of Health, France; Yamanouchi

Completed

Evaluation of Tamsulosin in the Treatment of Ureteral Stones (TAMSULOSINE)

Ureteral Calculi | Ureterolithiasis

France
JW Pharmaceutical

Completed

Efficacy and Safety of Silodosin on Voiding Dysfunction Associated With Neurogenic Bladder

Neurogenic Bladder | Voiding Dysfunction

Korea, Republic of
Sanofi

Completed

ALF-ONE : ALFuzosin ONcE Daily

Prostatic Hyperplasia
Jagiellonian University

Recruiting

Activity of Chronic Inflammation in PCOS

Polycystic Ovary Syndrome

Poland
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Withdrawn

A Cytomegalovirus-Directed Vaccine (CMV-alphaDC1) for Preventing Cytomegalovirus Infection or Reactivation in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Hematopoietic and Lymphoid System Neoplasm | Cytomegaloviral Infection

United States
Cedars-Sinai Medical Center

Recruiting

Terazosin Effect on Cardiac Changes in Early Parkinson's Disease

REM Sleep Behavior Disorder | Pre-motor Parkinson's Disease | Symptomatic Parkinson Disease

United States
University of Iowa
Michael J. Fox Foundation for Parkinson's Research

Active, not recruiting

Target Engagement of Terazosin in Healthy Adults

Healthy

United States
Siami, Paul F., M.D.
GlaxoSmithKline

Completed

Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
Memorial Health University Medical Center

Unknown

Hernia Surgery Urinary Retention

Hernia | Urinary Retention

United States
Chesapeake Urology Research Associates
Sanofi

Completed

An Efficacy Study to Evaluate Alfuzosin to Treat Men With Erectile Dysfunction and Mild Lower Urinary Tract Symptoms

Lower Urinary Tract Symptoms | Erectile Dysfunction

United States
Boehringer Ingelheim

Completed

Observational Study of ALNA® (Tamsulosin) in Patients With Benign Prostatic Hyperplasia (BPH)

Prostatic Hyperplasia
RECORDATI GROUP

Completed

Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia (SiRE)

Benign Prostatic Hyperplasia

Italy
Sanofi

Completed

Once Daily Given Alfuzosin in the Treatment of BPH

Benign Prostatic Hyperplasia

Hungary
Sanofi

Completed

Multicenter Prospective Study on the Changes of Sexual Function Following Treatment With Alfuzosin (Xatral XL®) in Patients With Benign Prostate Hypertrophy

BPH/LUTS/Sexual Functions

Korea, Republic of
Sanofi

Completed

The Efficacy, Onset of Effect, and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Randomized, Placebo-Controlled Trial Using an Acute International Prostate Score (ALF-ACUTE)

Benign Prostatic Hyperplasia

United States
Duke University
Genzyme, a Sanofi Company

Completed

How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis

Kidney Failure, Chronic | Hyperparathyroidism, Secondary

United States
Emory University

Terminated

Mineral Metabolism and Vascular Effects of Vitamin D Therapy in Kidney Transplant Patients (PAD)

Hyperparathyroidism, Secondary

United States
Hackensack Meridian Health

Recruiting

Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery

Urinary Retention

United States
Allegheny Singer Research Institute (also known...
Johns Hopkins University

Recruiting

Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery

Urinary Retention Postoperative

United States
NorthShore University HealthSystem

Completed

Effect of Preoperative Tamsulosin on Postoperative Urinary Retention

Postoperative Retention of Urine

United States
Mansoura University

Completed

Medical Expulsive Therapy Post-SWL For Renal Stones

Urologic Diseases | Urolithiasis | Stone, Kidney

Egypt
University of Louisville

Withdrawn

The Acute Cardiovascular Effects of Nicotine in E-cigarettes (ACE) Study (ACE)

Nicotine | Cigarette Smoking Toxicity | Acute Cardiovascular Disease

United States
Sanofi

Completed

Efficacy and Safety of SL77.0499-10 (Alfuzosin) Versus Placebo and Tamsulosin in Japanese Patients With Benign Prostatic Hyperplasia

Prostatic Hyperplasia

Japan
Sanofi

Completed

ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPH

Prostatic Hyperplasia | Acute Urinary Retention
US Department of Veterans Affairs

Completed

Prazosin Treatment for Combat Trauma PTSD (Post-Traumatic Stress Disorder) Nightmares and Sleep Disturbance

Stress Disorder, Post-Traumatic

United States
Rainier Associates

Unknown

Feasibility Study: The Effect of Prazosin for Nighttime Symptoms of Civilian PTSD

Stress Disorders, Post-Traumatic

United States
Jewish Hospital, Cincinnati, Ohio

Terminated

Tamsulosin to Prevent Postoperative Urinary Retention in Laparoscopic Inguinal Hernia Repair

Post Operative Urinary Retention

United States
National Institute of Diabetes and Digestive and...
University of Pennsylvania

Completed

Trial to Compare Alfuzosin Versus Placebo in the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Prostatitis

United States, Canada
University of Michigan

Terminated

Trial of Prophylactic Tamsulosin for Postoperative Urinary Retention in Primary Total Hip and Knee Arthroplasty Patients

Postoperative Urinary Retention

United States

Search clinical trials for: Alpha-1 MP

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Switzerland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations